Most Recent
The Full Federal Court has rejected an Australian inventor’s appeal of a ruling that found three manufacturers of essential oil products did not infringe his patent because the oil was a “staple commercial product”.
Melbourne-based joint venture Shepparton Partners Collective has appealed a $1.2 million judgment which found it infringed software developer QAD's copyright by failing to pay a transfer fee to retain the licence after it acquired the iconic SPC Ardmona cannery in Victoria from Coca-Cola Amatil for $40 million.
Cyber security company Secure Logic Group has won an injunction barring two former executives from using confidential information, but the victory is a Pyrrhic one for the firm, whose covert surveillance of one of the executives could lead to criminal charges.
Buffet dining pioneer Sizzler, which closed its last Australian restaurants in November, has settled a trade mark dispute with Brisbane-based chain Burger Urge over a chicken burger known as "the Sizzle".
A judge has ordered buffet restaurant pioneer Sizzler to amend its pleadings in a trade mark stoush with Brisbane-based restaurant Burger Urge to bring them in line with a summary judgment application that includes sandwiches among the classes of allegedly infringed goods.
US drug company Merck Sharp & Dohme has settled trade mark litigation brought by German drug maker Merck KGaA alleging it violated a 1970 agreement by using the "Merck" mark in Australia.
Buffet restaurant pioneer Sizzler is seeking a quick win in its trade mark stoush with Brisbane-based Burger Urge tossed, telling a court it will be seeking summary judgment in its favour.
The Brisbane-based burger chain at the centre of a trademark stoush with buffet bar pioneer Sizzler has agreed to refrain from its allegedly infringing trade mark use until the case is decided.
A court has barred US drug company Merck Sharp & Dohme from denying that an agreement made with German pharmaceutical company Merck KGaA was governed by German law, settling a key question before a trade mark case between the two drug giants goes to trial.